Top Watchlist Movers from Last Week
2/7/26
SEQH CAPITAL RESEARCH
TOP MOVERS REPORT
RESEARCH DESK
7 FEBRUARY 2026
Top movers on the SEQH nuclear watchlist this week were NNE, UUUU, ASPI, DNN, and NXEbased on 5‑day percentage price change and volatility.
Nano Nuclear Energy (NNE)
Price action: NNE closed at 29.20 on February 6, up 11.8% day‑on‑day and swinging over 10% intraday, capping a volatile week where the name rebounded off the mid‑20s.
Why it’s moving: The stock is reacting to heavy insider selling over the past 90 days (nearly 3.98M shares sold) and a mixed rating backdrop (two Strong Buys, several Buys, but also a Sell), which has kept volatility elevated even as speculative nuclear capital continues to rotate into the name.
Near‑term catalysts:
Q1 2026 earnings due before the market opens Thursday, February 12, with Street expecting a quarterly loss of about 0.32 per share and roughly 1.00 per share for FY26.
Any update on commercialization timelines for its micro‑reactor concepts and additional institutional‑ownership data will likely be key sentiment drivers.
Energy Fuels (UUUU)
Price action: UUUU is trading around the low‑20s after closing at 21.22 on February 6, up over 8% on the day but coming off a sharp 6.9–7.1% decline earlier in the week, highlighting very choppy tape.
Why it’s moving: The stock sold off after a 7.1% drop to 20.84 on Monday, with ~14.7M shares changing hands, followed by another session where it closed at 20.88, down almost 7% on the day as investors digested profit‑taking after a multi‑hundred‑percent 12‑month run and the broader uranium pullback.
Near‑term catalysts:
Ongoing analyst reassessments: Roth MKM recently upgraded from Sell to Neutral and raised the target from 13.00 to 15.50, while HC Wainwright reiterated a 26.75 target, keeping a wide valuation band in play.
Further operating updates around U.S. uranium and rare‑earth output at White Mesa and any new offtake or government‑linked contracts can quickly reset the risk/reward profile.
ASP Isotopes (ASPI)
Price action: ASPI has retraced from the high‑single digits to close near 5.2 on February 5 after trading above 8.2 late in January, implying a ~35–40% drawdown over roughly two weeks and a double‑digit weekly decline.
Why it’s moving: The stock rallied 13.2% intraday to 8.27 on January 22 on nearly 4.9M shares traded as investors responded to a growing isotopes story and positive sell‑side commentary, but subsequent profit‑taking and risk‑off flows in speculative nuclear names have driven a sharp pullback.
Near‑term catalysts:
The company is expected to transition to revenue‑positive operations in 2026, leveraging laser‑based quantum enrichment and commercial shipments of isotopes such as ytterbium‑176 and silicon‑28, which should be key milestones for rerating.
Street still carries a consensus Hold with a 13.00 price target and a wide 11–15 range, so any update on the Renergen‑linked helium platform or new customer contracts could close the expectation gap.
Denison Mines (DNN)
Price action: DNN traded as high as 4.11 and last around 4.07 on February 2, up 7.5% intraday versus a prior 3.78 close, and sits near the upper end of its 52‑week 1.08–4.43 band after more than a 100% 12‑month advance.
Why it’s moving: The recent 7.5% spike came on 5.1M shares, well below its 54.1M average volume, suggesting price is being driven more by positioning and sentiment than by incremental liquidity, with uranium‑complex flows and speculative interest in Athabasca Basin developers acting as key tailwinds.
Near‑term catalysts:
Continued analyst support, including an “outperform” stance from Raymond James, keeps the name in the preferred‑uranium‑equity basket.
Project de‑risking updates, including permitting or advancement at Wheeler River, will likely dictate whether the recent breakout above the 50‑day moving average (around 3.09) can sustain.
NexGen Energy (NXE)
Price action: NXE recently printed new 52‑week highs, with the NYSE line hitting 12.27 and last trading around 12.0 on heavy volume near 9.2M shares, while the Toronto listing reached an intraday high of 18.04 Canadian dollars before settling in the mid‑teens.
Why it’s moving: The move is being driven by sustained uranium‑price strength and a cluster of price‑target hikes: Stifel and TD lifted targets to 20.00 Canadian dollars with Canaccord at 18.50, while the average rating remains firmly in Buy territory and the consensus target sits slightly below current spot, encouraging momentum traders.
Near‑term catalysts:
Further progress on the flagship Rook I project, including permitting, financing, and offtake visibility, remains the primary medium‑term driver.
With a strong balance sheet (quick ratio around 8.2) but negative EPS and a 35.5 debt‑to‑equity ratio, any definitive construction or funding decision will be closely watched by both fundamental and event‑driven capital.
SEQH Capital Research – Upgrade to Premium
If you found this high‑level watchlist snapshot useful, consider becoming a paid subscriber to the SEQH Capital Research Substack. Paid members receive:
Full access to all premium reports, including detailed company deep dives, macro uranium and nuclear‑fuel‑cycle views, and special situation write‑ups each week.
Our institutional‑grade, weekly deep dive on the SEQH model nuclear fund: portfolio positioning, top active overweights/underweights, risk‑factor attribution, and scenario analysis for key holdings across the entire nuclear value chain.
Joining the premium tier is the most direct way to stay aligned with SEQH’s real‑time research process while supporting continued production of differentiated nuclear‑sector coverage for professional and serious individual investors.